These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11585707)

  • 1. Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells.
    Ullrich O; Grune T
    Free Radic Biol Med; 2001 Oct; 31(7):887-93. PubMed ID: 11585707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones.
    Ullrich O; Reinheckel T; Sitte N; Hass R; Grune T; Davies KJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6223-8. PubMed ID: 10339569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress.
    Ullrich O; Ciftci O; Hass R
    Free Radic Biol Med; 2000 Nov; 29(10):995-1004. PubMed ID: 11084288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors.
    Mimnaugh EG; Yunmbam MK; Li Q; Bonvini P; Hwang SG; Trepel J; Reed E; Neckers L
    Biochem Pharmacol; 2000 Nov; 60(9):1343-54. PubMed ID: 11008128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of DNA binding on the degradation of oxidized histones by the 20S proteasome.
    Ullrich O; Sitte N; Sommerburg O; Sandig V; Davies KJ; Grune T
    Arch Biochem Biophys; 1999 Feb; 362(2):211-6. PubMed ID: 9989929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity.
    Bakondi E; Catalgol B; Bak I; Jung T; Bozaykut P; Bayramicli M; Ozer NK; Grune T
    Free Radic Biol Med; 2011 Jan; 50(1):86-92. PubMed ID: 20977936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear proteasome and the degradation of oxidatively damaged proteins.
    Voss P; Grune T
    Amino Acids; 2007; 32(4):527-34. PubMed ID: 17103119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP-mediated proteasome activation: a co-ordination of DNA repair and protein degradation?
    Arnold J; Grune T
    Bioessays; 2002 Nov; 24(11):1060-5. PubMed ID: 12386937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation.
    Catalgol B; Wendt B; Grimm S; Breusing N; Ozer NK; Grune T
    Free Radic Biol Med; 2010 Mar; 48(5):673-80. PubMed ID: 20025963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells.
    Dou QP; McGuire TF; Peng Y; An B
    J Pharmacol Exp Ther; 1999 May; 289(2):781-90. PubMed ID: 10215653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turnover of oxidatively damaged nuclear proteins in BV-2 microglial cells is linked to their activation state by poly-ADP-ribose polymerase.
    Ullrich O; Diestel A; Bechmann I; Homberg M; Grune T; Hass R; Nitsch R
    FASEB J; 2001 Jun; 15(8):1460-2. PubMed ID: 11387257
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment.
    Cervantes-Laurean D; Roberts MJ; Jacobson EL; Jacobson MK
    Free Radic Biol Med; 2005 Mar; 38(6):786-95. PubMed ID: 15721989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro.
    Mayer-Kuckuk P; Ullrich O; Ziegler M; Grune T; Schweiger M
    Biochem Biophys Res Commun; 1999 Jun; 259(3):576-81. PubMed ID: 10364460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome.
    Grune T; Reinheckel T; Davies KJ
    J Biol Chem; 1996 Jun; 271(26):15504-9. PubMed ID: 8663134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
    Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells.
    Grune T; Reinheckel T; North JA; Li R; Bescos PB; Shringarpure R; Davies KJ
    FASEB J; 2002 Oct; 16(12):1602-10. PubMed ID: 12374783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors.
    Wesierska-Gadek J; Bohrn E; Herceg Z; Wang ZQ; Wurzer G
    J Cell Biochem; 2000 Jun; 78(4):681-96. PubMed ID: 10861865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).
    Boulikas T
    Anticancer Res; 1991; 11(2):489-527. PubMed ID: 1905900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress.
    Reinheckel T; Ullrich O; Sitte N; Grune T
    Arch Biochem Biophys; 2000 May; 377(1):65-8. PubMed ID: 10775442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.